145 related articles for article (PubMed ID: 19590073)
1. The intracellular localization and oligomerization of chicken invariant chain with major histocompatibility complex class II subunits.
Ye H; Xu FZ; Yu WY
Poult Sci; 2009 Aug; 88(8):1594-600. PubMed ID: 19590073
[TBL] [Abstract][Full Text] [Related]
2. Intracellular localization and association of MHC class I with porcine invariant chain.
Xu FZ; Wu SG; Yu WY
Genet Mol Res; 2013 Mar; 12(1):693-701. PubMed ID: 23546951
[TBL] [Abstract][Full Text] [Related]
3. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
4. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).
Zhong G; Castellino F; Romagnoli P; Germain RN
J Exp Med; 1996 Nov; 184(5):2061-6. PubMed ID: 8920896
[TBL] [Abstract][Full Text] [Related]
5. Allele-dependent association of chicken MHC class I molecules with the invariant chain.
Chen F; Pan L; Zhang J; Zhou X; Li J; Yu W
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):273-80. PubMed ID: 24948007
[TBL] [Abstract][Full Text] [Related]
6. Assembly of major histocompatibility complex class II subunits with invariant chain.
Neumann J; Koch N
FEBS Lett; 2005 Nov; 579(27):6055-9. PubMed ID: 16242130
[TBL] [Abstract][Full Text] [Related]
7. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
Powis SJ
FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional binding of invariant chain peptides to an MHC class II molecule.
Günther S; Schlundt A; Sticht J; Roske Y; Heinemann U; Wiesmüller KH; Jung G; Falk K; Rötzschke O; Freund C
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22219-24. PubMed ID: 21115828
[TBL] [Abstract][Full Text] [Related]
9. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
10. Self-release of CLIP in peptide loading of HLA-DR molecules.
Kropshofer H; Vogt AB; Stern LJ; Hämmerling GJ
Science; 1995 Nov; 270(5240):1357-9. PubMed ID: 7481823
[TBL] [Abstract][Full Text] [Related]
11. A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.
Temme S; Zacharias M; Neumann J; Wohlfromm S; König A; Temme N; Springer S; Trowsdale J; Koch N
J Biol Chem; 2014 Jan; 289(2):639-53. PubMed ID: 24214983
[TBL] [Abstract][Full Text] [Related]
12. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.
Kropshofer H; Vogt AB; Hämmerling GJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8313-7. PubMed ID: 7667286
[TBL] [Abstract][Full Text] [Related]
13. Sea bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility complex: sequencing and structural analysis using 3D homology modelling.
Silva DS; Reis MI; Nascimento DS; do Vale A; Pereira PJ; dos Santos NM
Mol Immunol; 2007 Jul; 44(15):3758-76. PubMed ID: 17512596
[TBL] [Abstract][Full Text] [Related]
14. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.
Zhu Y; Rudensky AY; Corper AL; Teyton L; Wilson IA
J Mol Biol; 2003 Feb; 326(4):1157-74. PubMed ID: 12589760
[TBL] [Abstract][Full Text] [Related]
16. Assembly, Intracellular Transport, and Release of MHC Class II Peptide Receptors.
Temme S; Temme N; Koch N
Methods Mol Biol; 2019; 1988():297-314. PubMed ID: 31147949
[TBL] [Abstract][Full Text] [Related]
17. Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.
Verreck FA; Fargeas CA; Hämmerling GJ
Eur J Immunol; 2001 Apr; 31(4):1029-36. PubMed ID: 11298327
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and site-directed mutagenesis of leucine-based sorting motifs of the porcine invariant chain.
Xu FZ; Dai Y; Li LM; Ding XL; Yu WY
Genet Mol Res; 2013 Jan; 12(4):4489-99. PubMed ID: 23315869
[TBL] [Abstract][Full Text] [Related]
19. Stoichiometry of HLA class II-invariant chain oligomers.
Koch N; Zacharias M; König A; Temme S; Neumann J; Springer S
PLoS One; 2011 Feb; 6(2):e17257. PubMed ID: 21364959
[TBL] [Abstract][Full Text] [Related]
20. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]